ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer

ONWARD Medical N.V. Partners with Lovell Government Services for US Veterans Affairs Procurement

Eindhoven's ONWARD Medical raised €50M through private placement to develop therapies for spinal cord injury and movement disabilities.

ONWARD Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA

Launched ONWARD Medical Secures Exclusive Rights to WIMAGINE® Brain-Computer Interface Technology from Clinatec for its ARC-BCI™ System.

ONWARD Medical Secures Exclusive Rights to WIMAGINE® Brain-Computer Interface Technology from Clinatec for its ARC-BCI™ System.

ONWARD Medical N.V. Obtains Debt Financing of up to €52.5 Million with Runway Growth Capital LLC

ONWARD Medical successfully raised €20 million in a capital increase to develop and commercialize breakthrough therapies for spinal cord injury.

ONWARD Medical is a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries. ONWARD Medical’s work builds on more than a decade of basic science and preclinical research conducted at the world’s leading neuroscience laboratories. ARC Therapy, which can be delivered by implantable (ARC-IM) or external (ARC-EX) syst

ONWARD Medical

Funding history

Recent signals